184 related articles for article (PubMed ID: 30902727)
1. Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.
Delyon J; Rabate C; Euvrard S; Harwood CA; Proby C; Güleç AT; Seçkin D; Del Marmol V; Bouwes-Bavinck JN; Ferrándiz-Pulido C; Ocampo MA; Barete S; Legendre C; Francès C; Porcher R; Lebbe C;
J Am Acad Dermatol; 2019 Aug; 81(2):448-455. PubMed ID: 30902727
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.
Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A
Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080
[TBL] [Abstract][Full Text] [Related]
3. Kaposi Sarcoma in the Era of Rapamycin Remains a Therapeutic Challenge in Organ Transplant Recipients.
Tunçer Vural A; Karataş Toğral A; Güleç AT; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):25-27. PubMed ID: 29527986
[TBL] [Abstract][Full Text] [Related]
4. Risk of Kaposi sarcoma after solid organ transplantation in the United States.
Cahoon EK; Linet MS; Clarke CA; Pawlish KS; Engels EA; Pfeiffer RM
Int J Cancer; 2018 Dec; 143(11):2741-2748. PubMed ID: 29987894
[TBL] [Abstract][Full Text] [Related]
5. The role of the transplant physician in the management of skin cancers after organ transplantation.
Morelon E; Mahe E; Touraine JL
Cancer Treat Res; 2009; 146():377-90. PubMed ID: 19415217
[No Abstract] [Full Text] [Related]
6. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
[TBL] [Abstract][Full Text] [Related]
7. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
Detroyer D; Deraedt K; Schöffski P; Hauben E; Lagrou K; Naesens M; Delforge ML; Kuypers D
Transpl Infect Dis; 2015 Apr; 17(2):303-7. PubMed ID: 25645490
[TBL] [Abstract][Full Text] [Related]
8. Malignancy after solid organ transplantation: an overview.
Zafar SY; Howell DN; Gockerman JP
Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
[TBL] [Abstract][Full Text] [Related]
9. Role of HHV-8 and mTOR pathway in post-transplant Kaposi sarcoma staging.
Hernández-Sierra A; Rovira J; Petit A; Moya-Rull D; Mazuecos MA; Sánchez-Fructuoso AI; Errasti P; Idoate MÁ; Cruzado JM; Vidal A; Diekmann F; Oppenheimer F; Campistol JM; Revuelta I
Transpl Int; 2016 Sep; 29(9):1008-16. PubMed ID: 27208691
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Kaposi's sarcoma after solid organ transplantation.
Shepherd FA; Maher E; Cardella C; Cole E; Greig P; Wade JA; Levy G
J Clin Oncol; 1997 Jun; 15(6):2371-7. PubMed ID: 9196152
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient.
Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH
Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613
[TBL] [Abstract][Full Text] [Related]
12. [Remission of an iatrogenic Kaposi sarcoma in a patient with myasthenia gravis after switching immunosuppressive therapy to the mTOR inhibitor everolimus].
Krengel S; Satzger I; Alter M; Kapp A; Gutzmer R
Hautarzt; 2012 Jul; 63(7):573-6. PubMed ID: 22751858
[TBL] [Abstract][Full Text] [Related]
13. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
[TBL] [Abstract][Full Text] [Related]
14. Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.
Charpentier C; Delyon J; Glotz D; Peraldi MN; Rerolle JP; Barrou B; Ducroux E; Coilly A; Legeai C; Barete S; Lebbé C
Transplantation; 2019 Jan; 103(1):e22-e28. PubMed ID: 30273235
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Kaposi sarcoma in a lung transplant recipient: therapy with mammalian target of rapamycin inhibitor and immunosuppression reduction.
Lund MB; Paulsen V; Aukrust P
J Heart Lung Transplant; 2013 Mar; 32(3):376-7. PubMed ID: 23305694
[No Abstract] [Full Text] [Related]
16. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant Kaposi sarcoma: Analysis of a series of 13 patients.
González-Cruz C; Ferrándiz-Pulido C; Ferrer Fàbregas B; García-Patos Briones V
Med Clin (Barc); 2021 Oct; 157(7):339-343. PubMed ID: 34246484
[TBL] [Abstract][Full Text] [Related]
18. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.
Yaich S; Charfeddine K; Zaghdane S; El Aoud N; Jarraya F; Kharrat M; Hachicha J
Transplant Proc; 2012 Nov; 44(9):2824-6. PubMed ID: 23146533
[TBL] [Abstract][Full Text] [Related]
20. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.
Campistol JM; Gutierrez-Dalmau A; Torregrosa JV
Transplantation; 2004 Mar; 77(5):760-2. PubMed ID: 15021843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
